Classical pharmacological studies have defined three classes of opiate receptors-the delta, kappa and mu. The delta receptors bind with high affinity to enkephalins. Prolonged exposure to opiates cause desensitization and down-regulation of the delta receptor. This has been proposed to play a significant role in the development of opiate tolerance and dependence. However, little is known regarding the molecular basis for desensitization and down-regulation of the receptor. In this grant application we propose to address this issue. The cloning of the delta opiate receptor cDNA from NG1O8-15 cells has confirmed that these receptors belong to the 'G-protein coupled receptor' family. Accordingly, the opiate receptors share many structural features with the G-protein coupled receptors including rhodopsin and beta adrenergic receptor. Many posttranslational modifications are found to regulate these other receptors as revealed by mutational analyses. Recently phosphorylation of the beta adrenergic receptor and rhodopsin has been implicated in desensitization of these receptors. The objective of the studies proposed in this grant application is to examine the involvement of phosphorylation in the regulation of opiate receptor. The delta opiate receptor will be subjected to in vitro and in situ phosphorylation and the phosphorylated receptor will be immunoaffinity purified. Phosphopeptides will be generated, isolated and characterized. The phosphopeptide maps obtained from the desensitized receptors will be compared to the normal receptor. The involvement of specific phosphorylation sites on the desensitization will be analyzed by site-specific mutagenesis. The effect of mutations on the desensitization and down regulation will be examined. The studies described in this grant application will provide an important insight towards the role of phosphorylation in the development of opiate tolerance and dependence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA008863-01A1
Application #
2121663
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1995-03-15
Project End
1998-01-31
Budget Start
1995-03-15
Budget End
1996-01-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
New York University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Fricker, Lloyd D; Devi, Lakshmi A (2018) Orphan neuropeptides and receptors: Novel therapeutic targets. Pharmacol Ther 185:26-33
Lueptow, Lindsay M; Devi, Lakshmi A; Fakira, Amanda K (2018) Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders. Prog Mol Biol Transl Sci 159:1-25
Margolis, Elyssa B; Fujita, Wakako; Devi, Lakshmi A et al. (2017) Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor. Neuropharmacology 123:420-432
Reckziegel, PatrĂ­cia; Festuccia, William T; Britto, Luiz R G et al. (2017) A novel peptide that improves metabolic parameters without adverse central nervous system effects. Sci Rep 7:14781
Heimann, Andrea S; Gupta, Achla; Gomes, Ivone et al. (2017) Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states. PLoS One 12:e0187306
Gomes, Ivone; Sierra, Salvador; Devi, Lakshmi A (2016) Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay. Curr Protoc Pharmacol 75:2.16.1-2.16.31
Gomes, Ivone; Bobeck, Erin N; Margolis, Elyssa B et al. (2016) Identification of GPR83 as the receptor for the neuroendocrine peptide PEN. Sci Signal 9:ra43
Wardman, Jonathan H; Gomes, Ivone; Bobeck, Erin N et al. (2016) Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake. Sci Signal 9:ra55
Gupta, Achla; Gomes, Ivone; Bobeck, Erin N et al. (2016) Collybolide is a novel biased agonist of ?-opioid receptors with potent antipruritic activity. Proc Natl Acad Sci U S A 113:6041-6
Gomes, Ivone; Ayoub, Mohammed Akli; Fujita, Wakako et al. (2016) G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol 56:403-25

Showing the most recent 10 out of 75 publications